Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-05

Clinical Trial Update: Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

View source ↗

Summary

A Yale-sponsored clinical trial evaluating whether stress hyperglycemia can serve as an indicator for type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Stress Hyperglycemia, Diabetes Mellitus Type 2 | Status: TERMINATED